{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["91(7-S)"],"submitter":["Luzzi S"],"pubmed_abstract":["<h4>Background</h4>Adoptive immunotherapies are among the pillars of ongoing biological breakthroughs in neuro-oncology, as their potential applications are tremendously wide. The present literature review comprehensively classified adoptive immunotherapies in neuro-oncology, provides an update, and overviews the main translational challenges of this approach.<h4>Methods</h4>The PubMed/MEDLINE platform, Medical Subject Heading (MeSH) database, and ClinicalTrials.gov website were the sources. The MeSH terms \"Immunotherapy, Adoptive,\" \"Cell- and Tissue-Based Therapy,\" \"Tissue Engineering,\" and \"Cell Engineering\" were combined with \"Central Nervous System,\" and \"Brain.\" \"Brain tumors\" and \"adoptive immunotherapy\" were used for a further unrestricted search. Only articles published in the last"],"journal":["Acta bio-medica : Atenei Parmensis"],"pagination":["18-31"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7975830"],"repository":["biostudies-literature"],"pubmed_title":["Adoptive immunotherapies in neuro-oncology: classification, recent advances, and translational challenges."],"pmcid":["PMC7975830"],"pubmed_authors":["Magistrali M","Luzzi S","Mosconi M","Savasta S","Giotta Lucifero A","Foiadelli T","Brambilla I"],"additional_accession":[]},"is_claimable":false,"name":"Adoptive immunotherapies in neuro-oncology: classification, recent advances, and translational challenges.","description":"<h4>Background</h4>Adoptive immunotherapies are among the pillars of ongoing biological breakthroughs in neuro-oncology, as their potential applications are tremendously wide. The present literature review comprehensively classified adoptive immunotherapies in neuro-oncology, provides an update, and overviews the main translational challenges of this approach.<h4>Methods</h4>The PubMed/MEDLINE platform, Medical Subject Heading (MeSH) database, and ClinicalTrials.gov website were the sources. The MeSH terms \"Immunotherapy, Adoptive,\" \"Cell- and Tissue-Based Therapy,\" \"Tissue Engineering,\" and \"Cell Engineering\" were combined with \"Central Nervous System,\" and \"Brain.\" \"Brain tumors\" and \"adoptive immunotherapy\" were used for a further unrestricted search. Only articles published in the last","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Jun","modification":"2025-04-04T08:27:45.162Z","creation":"2025-04-04T08:27:45.162Z"},"accession":"S-EPMC7975830","cross_references":{"pubmed":["32608373"],"doi":["10.23750/abm.v91i7-S.9952"]}}